Immunoglobulin G1 [351-alanine,386-alanine,387-alanine] anti-(human epidermal growth factor receptor HER2) (human-Mus musculus monoclonal IMM2902 ?1-chain), disulfide with 1-125-signal regulatory protein ? [80-alanine] (human isoform 4 variant) fusion protein with peptide linker ((GGGGS)3) fusion protein with human-Mus musculus monoclonal IMM2902 ?-chain, dimer
Advanced Lung Cancer
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.monoclonal_antibodyPhase 1/2Active
CC
45/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 81/ 100
Competitive context
303 Active assets in the Advanced Lung Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Carboplatin SystImmune Inc. | Phase 4 | BB |
CIS-DIAMMINEDICHLOROPLATINUM II University of Vermont | Phase 4 | BB |
PROPOFOL Kaohsiung Medical University Chung-Ho Memorial Hospital | Phase 4 | BB |
ETOPOSIDE SystImmune Inc. | Phase 3 | BB |
Nivolumab University of Chicago | Phase 4 | BB |
View all 50 →
Same molecule, other indications
Immunoglobulin G1 [351-alanine,386-alanine,387-alanine] anti-(human epidermal growth factor receptor HER2) (human-Mus musculus monoclonal IMM2902 ?1-chain), disulfide with 1-125-signal regulatory protein ? [80-alanine] (human isoform 4 variant) fusion protein with peptide linker ((GGGGS)3) fusion protein with human-Mus musculus monoclonal IMM2902 ?-chain, dimer is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →